Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)

Clinical trial NCT06088381 · RECRUITING

Trial details

NCT number: NCT06088381
Sponsor: University of Maryland, Baltimore
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer Head and Neck Squamous Cell Carcinoma Oropharynx Cancer Oropharynx Squamous Cell Carcinoma HPV Positive Oropharyngeal Squamous Cell Carcinoma

Start date: 2024-03-07
Primary completion: 2028-12-18
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.